Treatment of chronic heart failure in Germany: a retrospective database study

Clinical Research in Cardiology

Volumn 106, Issue 11, 2017, Pages 923-932

  Störk, Stefan ^a   Handrock, Renate ^b   Jacob, Josephine ^c,d   Walker, Jochen ^c,d   Calado, Frederico ^e   Lahoz, Raquel ^e   Hupfer, Stephan ^b   Klebs, Sven ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Novartis Pharma GmbH   (Germany)

^c ELSEVIER MASSON   (France)

^d Health Risk Institute   (Germany)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cardiologist; Care pathway; Germany; Guidelines; Heart failure; Treatment pattern

Indexed keywords

ARTICLE; DATA ANALYSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FOLLOW UP; GERMANY; HEALTH INSURANCE; HEART FAILURE; HUMAN; INTERNAL MEDICINE; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; AGED; CARDIOLOGY; CLINICAL TRIAL; DISEASE MANAGEMENT; FACTUAL DATABASE; FEMALE; MALE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; PROTOCOL COMPLIANCE; STANDARDS; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOLOGY; DATABASES, FACTUAL; DISEASE MANAGEMENT; FEMALE; GERMANY; GUIDELINE ADHERENCE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85026922337     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-017-1138-6     Document Type: Article

References (26)

1. Mehrhof F, Loffler M, Gelbrich G et al (2010) A network against failing hearts—introducing the German “Competence Network Heart Failure”. Int J Cardiol 145:135–138
2. Tebbe U, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Strunz AM, Lins K, Bohm M (2014) Registry in Germany focusing on level-specific and evidence-based decision finding in the treatment of heart failure: REFLECT-HF. Clin Res Cardiol 103:665–673
3. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200
4. Nationale VersorgungsLeitlinien (NVL) guidelines for chronic heart failure v1.7. (2013) http://www.leitlinien.de/mdb/downloads/nvl/herzinsuffizienz/herzinsuffizienz-1aufl-vers7-lang.pdf. Accessed 10 Mar 2017
5. Zugck C, Franke J, Gelbrich G et al (2012) Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol 101:263–272
6. Rutten FH, Grobbee DE, Hoes AW (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 5:337–344
7. Franke J, Zugck C, Wolter JS et al (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1–10
8. Ke M, Zou D, Yuan Y, Li Y, Lin L, Hao J, Hou X, Kim HJ (2012) Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 24:999-e541
9. Braunwald E (1997) Shattuck lecture–cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360–1369
10. Braun V, Heintze C, Rufer V, Welke J, Stein T, Mehrhof F, Dini L (2011) Innovative strategy for implementing chronic heart failure guidelines among family physicians in different healthcare settings in Berlin. Eur J Heart Fail 13:93–99
11. Dini L, Heintze C, Welke J, Stein T, Rufer V, Braun V (2010) Are there any differences in guideline adherence to pharmacotherapy of heart failure between individual GP practices and Medical Care Centres (MCCs)? Z Evid Fortbild Qual Gesundhwes 104:113–119
12. Riens B and Bätzing-Feigenbaum J (2014) Leitliniengerechte therapie bei herzinsuffizienz. http://www.versorgungsatlas.de/fileadmin/ziva_docs/47/Bericht_Herzinsuffizienz_20140911_1.pdf. Accessed 15 Feb 2017
13. Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442
14. Nationale VersorgungsLeitlinien (NVL) guidelines for chronic heart failure v1.4. (2011) http://www.leitlinien.de/mdb/downloads/nvl/herzinsuffizienz/archiv/hi-lang-1.4.pdf. Accessed 10 Mar 2017
15. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216
16. Stork S, Hense HW, Zentgraf C, Uebelacker I, Jahns R, Ertl G, Angermann CE (2008) Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study. Eur J Heart Fail 10:1236–1245
17. Bohm M, Tschope C, Wirtz JH, Lokies J, Turgonyi E, Bramlage P, Lins K, Strunz AM, Tebbe U (2015) Treatment of heart failure in real-world clinical practice: findings from the REFLECT-HF registry in patients with NYHA class II symptoms and a reduced ejection fraction. Clin Cardiol 38:200–207
18. von Scheidt W, Zugck C, Pauschinger M et al (2014) Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol 103:1006–1014
19. Andersohn F, Walker J (2016) Characteristics and external validity of the German Health Risk Institute (HRI) Database. Pharmacoepidemiol Drug Saf 25:106–109
20. Informed Health Online (2015) Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG). Health care in Germany: health insurance in Germany. https://www.ncbi.nlm.nih.gov/books/NBK298832/?report=reader#_NBK298832_pubdet. Accessed 27 Mar 2017
21. Maggioni AP, Anker SD, Dahlstrom U et al (2013) Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 15:1173–1184
22. Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS (2017) Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. doi:10.1002/ejhf.887 (Epub ahead of print)
23. Allen LA, Shetterly SM, Peterson PN et al (2014) Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure. Circ Heart Fail 7:43–50
24. Sharma K, Kass DA (2014) Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res 115:79–96
25. Angermann CE, Stork S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G (2012) Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail 5:25–35
26. Guder G, Stork S, Gelbrich G et al (2015) Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail 17:442–452